iSERA Lifesciences（534920）株式概要Covidh Technologies LimitedはインドでIT/ITES事業に従事している。 詳細534920 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績3/6財務の健全性4/6配当金0/6報酬過去1年間で収益は86.6%増加しました リスク分析過去1年間で株主の希薄化は大幅に進んだ 高いレベルの非現金収入 収益が 100 万ドル未満 ( ₹14M )意味のある時価総額がありません ( ₹652M )+1 さらなるリスクすべてのリスクチェックを見る534920 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹77.49444.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-134m336m2016201920222025202620282031Revenue ₹19.4mEarnings ₹3.5mAdvancedSet Fair ValueView all narrativesiSERA Lifesciences Limited 競合他社Telecanor GlobalSymbol: BSE:530595Market cap: ₹276.3mUnipro TechnologiesSymbol: BSE:540189Market cap: ₹131.8mIcodex Publishing SolutionsSymbol: BSE:544483Market cap: ₹672.4mSGL ResourcesSymbol: BSE:526544Market cap: ₹718.9m価格と性能株価の高値、安値、推移の概要iSERA Lifesciences過去の株価現在の株価₹77.4952週高値₹77.4952週安値₹1.50ベータ0.551ヶ月の変化0.44%3ヶ月変化108.31%1年変化n/a3年間の変化-83.51%5年間の変化-69.00%IPOからの変化-99.64%最新ニュースお知らせ • May 15iSERA Lifesciences Limited to Report Q4, 2026 Results on May 21, 2026iSERA Lifesciences Limited announced that they will report Q4, 2026 results on May 21, 2026Board Change • May 01High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. MD & Director Jayshree Suresh Jain is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Apr 02Covidh Technologies Limited Approves Directorate AppointmentsCovidh Technologies Limited at its EGM held on April 2, 2026 approved the appointment of Mr. Dhairyasheel Vasantrao Yadav as an Executive Director of the Company; approved the appointment of Mr. Nandkumar Subhash Kadam as an Executive Director of the Company; approved the appointment of Mr. Pratap Dadasaheb Deshmuk as a Non-Executive, Non-Independent Director of the Company and approved the appointment of Ms Ritu Dhanraj Garad as a Non-Executive, Non-Independent Director of the Company.お知らせ • Feb 24Covidh Technologies Limited (BSE:534920) entered into a non-binding letter of intent to acquire Isera Biological Private Limited.Covidh Technologies Limited (BSE:534920) entered into a non-binding letter of intent to acquire Isera Biological Private Limited on February 23, 2026. The proposed acquisition is subject to execution of definitive agreements, completion of satisfactory due diligence, receipt of necessary regulatory, statutory and shareholders' approvals, and fulfilment of agreed conditions precedent. Upon completion of the proposed transaction. iSERA shall become a wholly owned subsidiary of Covidh Technologies Limited.お知らせ • Feb 05Covidh Technologies Limited to Report Q3, 2026 Results on Feb 10, 2026Covidh Technologies Limited announced that they will report Q3, 2026 results on Feb 10, 2026New Risk • Nov 13New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 25x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-₹980k). Shareholders have been substantially diluted in the past year (over 25x increase in shares outstanding). Revenue is less than US$1m (₹2.7m revenue, or US$30k). Market cap is less than US$10m (₹75.3m market cap, or US$849.4k).最新情報をもっと見るRecent updatesお知らせ • May 15iSERA Lifesciences Limited to Report Q4, 2026 Results on May 21, 2026iSERA Lifesciences Limited announced that they will report Q4, 2026 results on May 21, 2026Board Change • May 01High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. MD & Director Jayshree Suresh Jain is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Apr 02Covidh Technologies Limited Approves Directorate AppointmentsCovidh Technologies Limited at its EGM held on April 2, 2026 approved the appointment of Mr. Dhairyasheel Vasantrao Yadav as an Executive Director of the Company; approved the appointment of Mr. Nandkumar Subhash Kadam as an Executive Director of the Company; approved the appointment of Mr. Pratap Dadasaheb Deshmuk as a Non-Executive, Non-Independent Director of the Company and approved the appointment of Ms Ritu Dhanraj Garad as a Non-Executive, Non-Independent Director of the Company.お知らせ • Feb 24Covidh Technologies Limited (BSE:534920) entered into a non-binding letter of intent to acquire Isera Biological Private Limited.Covidh Technologies Limited (BSE:534920) entered into a non-binding letter of intent to acquire Isera Biological Private Limited on February 23, 2026. The proposed acquisition is subject to execution of definitive agreements, completion of satisfactory due diligence, receipt of necessary regulatory, statutory and shareholders' approvals, and fulfilment of agreed conditions precedent. Upon completion of the proposed transaction. iSERA shall become a wholly owned subsidiary of Covidh Technologies Limited.お知らせ • Feb 05Covidh Technologies Limited to Report Q3, 2026 Results on Feb 10, 2026Covidh Technologies Limited announced that they will report Q3, 2026 results on Feb 10, 2026New Risk • Nov 13New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 25x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-₹980k). Shareholders have been substantially diluted in the past year (over 25x increase in shares outstanding). Revenue is less than US$1m (₹2.7m revenue, or US$30k). Market cap is less than US$10m (₹75.3m market cap, or US$849.4k).お知らせ • Nov 11Covidh Technologies Limited to Report Q2, 2026 Results on Nov 13, 2025Covidh Technologies Limited announced that they will report Q2, 2026 results on Nov 13, 2025Board Change • Sep 01High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. MD & Director Jayshree Jain is the most experienced director on the board, commencing their role in 2024. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Aug 04Covidh Technologies Limited, Annual General Meeting, Aug 26, 2025Covidh Technologies Limited, Annual General Meeting, Aug 26, 2025, at 12:00 Indian Standard Time.お知らせ • Aug 01Covidh Technologies Limited Announces Reconstitution of Committees of the BoardThe reconstitution of various Committees of the Board of Covidh Technologies Limited is as follows: For the Audit Committee, the members are as follows: S. No. 1, Apurva Pradeep Joshi, who serves as the Chairperson and is a Non-Executive Independent Director; S. No. 2, Rinku Saini, who is a Member and also a Non-Executive Independent Director; and S. No. 3, Mangina Srinivas Rao, who is a Member and a Non-Executive Independent Director. Moving on to the Nomination and Remuneration Committee (NRC), the members are: S. No. 1, Apurva Pradeep Joshi, serving as the Chairperson and a Non-Executive Independent Director; S. No. 2, Rinku Saini, who is a Member and a Non-Executive Independent Director; and S. No. 3, Mangina Srinivas Rao, who is a Member and a Non-Executive Independent Director. For the Stakeholders Relationship Committee (SRC), the members are: S. No. 1, Apurva Pradeep Joshi, who is the Chairperson and a Non-Executive Independent Director; S. No. 2, Rinku Saini, who is a Member and a Non-Executive Independent Director; and S. No. 3, Mangina Srinivas Rao, who is a Member and a Non-Executive Independent Director. Lastly, for the Risk Management Committee, the members are: S. No. 1, Apurva Pradeep Joshi, who serves as the Chairperson and is a Non-Executive Independent Director; S. No. 2, Rinku Saini, who is a Member and a Non-Executive Independent Director; and S. No. 3, Mangina Srinivas Rao, who is a Member and a Non-Executive Independent Director.お知らせ • Jul 29Covidh Technologies Limited to Report Q1, 2026 Results on Aug 01, 2025Covidh Technologies Limited announced that they will report Q1, 2026 results on Aug 01, 2025お知らせ • May 27Covidh Technologies Limited to Report Q4, 2025 Results on May 30, 2025Covidh Technologies Limited announced that they will report Q4, 2025 results at 12:15 PM, Indian Standard Time on May 30, 2025お知らせ • Mar 25Covidh Technologies Limited Announces Resignation of Ms. Vinita Dilip Modak as Independent DirectorCovidh Technologies Limited announced that Ms. Vinita Dilip Modak has resigned from the post of Independent Director from the Board of the Company with effect from the closure of business hour from March 24, 2025 due to other professional commitments. She has confirmed that there are no material reasons for her resignation other than those mentioned in her resignation letter. Name of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of Board Committees: Directorship of Davangere Sugar Company. Committees: Stakeholders Relationship Committee; Member of Committee in Davangere Sugar Company Limited, Corporate Social Responsibility Committee; Member of Committee in Davangere Sugar Company Limited.お知らせ • Feb 03Covidh Technologies Limited to Report Q3, 2025 Results on Feb 10, 2025Covidh Technologies Limited announced that they will report Q3, 2025 results on Feb 10, 2025お知らせ • Nov 09Covidh Technologies Limited to Report Q2, 2025 Results on Nov 13, 2024Covidh Technologies Limited announced that they will report Q2, 2025 results on Nov 13, 2024お知らせ • Oct 24Covidh Technologies Limited Announces Resignation of Suresh Fatehlalji Jain as Executive DirectorCovidh Technologies Limited announced that at the board meeting held on 24 October, 2024 approved the resignation of Mr. Suresh Fatehlalji Jain from the post of Executive Director of the Company with effect from 24 October, 2024 due to personal and unavoidable circumstances.お知らせ • Aug 30Covidh Technologies Limited Announces Board AppointmentsThe board of directors of Covidh Technologies Limited meeting held on August 28, 2024, considered and approved the appointment of Mr. Suresh Fatehlalji Jain as an Additional Executive Director of the company with effect from August 28, 2024 and Mrs. Jayshree Babulal Jain as an Additional Non-Executive Director of the company with effect from August 28, 2024. Mr. Suresh Fatehlalji Jain brings over seven years of rich experience in Marketing and Sales. Throughout his career, he has developed a strong acumen for market analysis, strategic planning, and driving sales growth. His expertise in these areas has enabled him to consistently deliver impressive results, positioning him as a key contributor to the success of the organizations he has served. Mr. Kumar's deep understanding of market dynamics and customer behavior makes him a highly effective leader in the marketing and sales domain. Mrs. Jayshree Babulal Jain has accumulated over four years of extensive experience in the fields of Administration and Operations. Her expertise lies in streamlining administrative processes and optimizing operational efficiency, contributing to the effective management and growth of the organizations She has been a part of. Her hands-on approach and in-depth knowledge make her a valuable asset in driving organizational success.お知らせ • Aug 12Covidh Technologies Limited, Annual General Meeting, Sep 30, 2024Covidh Technologies Limited, Annual General Meeting, Sep 30, 2024.お知らせ • Aug 07Covidh Technologies Limited to Report Q1, 2025 Results on Aug 12, 2024Covidh Technologies Limited announced that they will report Q1, 2025 results on Aug 12, 2024お知らせ • May 22Covidh Technologies Limited to Report Q4, 2024 Results on May 29, 2024Covidh Technologies Limited announced that they will report Q4, 2024 results on May 29, 2024New Risk • Jan 30New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 34x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹1.5m free cash flow). Shares are highly illiquid. Negative equity (-₹1.4m). Shareholders have been substantially diluted in the past year (over 34x increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (₹19.7m market cap, or US$237.2k).お知らせ • Jan 26Covidh Technologies Limited to Report Q3, 2024 Results on Feb 08, 2024Covidh Technologies Limited announced that they will report Q3, 2024 results on Feb 08, 2024お知らせ • Nov 04Covidh Technologies Limited to Report Q2, 2024 Results on Nov 10, 2023Covidh Technologies Limited announced that they will report Q2, 2024 results on Nov 10, 2023Board Change • Sep 18High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Sep 08Covidh Technologies Limited, Annual General Meeting, Sep 30, 2023Covidh Technologies Limited, Annual General Meeting, Sep 30, 2023, at 10:00 Indian Standard Time. Location: Flat No 302, Plot No 159, Ayyappa Society, Madhapur, Hyderabad 500081 Hyderabad Andhra Pradesh India Agenda: To receive, consider and adopt the Audited Balance Sheet as at 31st March 2023, the Profit and Loss Account for the year ended on that date, Cash flow for the year ended on that date and the Reports of the Directors and Auditors thereon.Board Change • Sep 04High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Aug 05Covidh Technologies Limited to Report Q1, 2024 Results on Aug 11, 2023Covidh Technologies Limited announced that they will report Q1, 2024 results on Aug 11, 2023お知らせ • May 23Covidh Technologies Limited to Report Fiscal Year 2023 Results on May 29, 2023Covidh Technologies Limited announced that they will report fiscal year 2023 results on May 29, 2023Board Change • May 02High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 20High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 06High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Feb 04Covidh Technologies Limited to Report Q3, 2023 Results on Feb 13, 2023Covidh Technologies Limited announced that they will report Q3, 2023 results on Feb 13, 2023Board Change • Nov 21High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Nov 06Covidh Technologies Limited to Report Q2, 2023 Results on Nov 14, 2022Covidh Technologies Limited announced that they will report Q2, 2023 results on Nov 14, 2022Board Change • Oct 11High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.お知らせ • Sep 07Covidh Technologies Limited, Annual General Meeting, Sep 29, 2022Covidh Technologies Limited, Annual General Meeting, Sep 29, 2022, at 10:00 Indian Standard Time. Location: House No.1-10-27/34/15A, Prakash Nagar, Begumpet, Secunderabad Hyderabad Indiaお知らせ • Aug 30Covidh Technologies Limited to Report Fiscal Year 2022 Final Results on Sep 05, 2022Covidh Technologies Limited announced that they will report fiscal year 2022 final results at 3:30 PM, Indian Standard Time on Sep 05, 2022お知らせ • Aug 08Covidh Technologies Limited to Report Q1, 2023 Results on Aug 13, 2022Covidh Technologies Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 13, 2022お知らせ • Jun 12Covidh Technologies Limited Appoints Hema Gupta as Whole-Time Company Secretary and Compliance OfficerThe board of directors of Covidh Technologies Limited at its meeting held on June 11, 2022, appointed, Mrs. Hema Kumari, an Associate member of Institute of Company Secretaries of India (Membership No: A48642) as whole-time company secretary and compliance officer, with the effect from June 11, 2022.お知らせ • May 31Covidh Technologies Limited Approves Resignation of Mr. Phani Kumar.B as CFO, Effective on May 31, 2022Covidh Technologies Limited announced that at its board meeting held on May 30, 2022, the board approved the resignation of Mr. Phani Kumar.B as CFO of the company with effect from closing of the business hours of the 31st May, 2022.お知らせ • May 20Covidh Technologies Limited to Report Q4, 2022 Results on May 30, 2022Covidh Technologies Limited announced that they will report Q4, 2022 results on May 30, 2022お知らせ • Feb 16Covidh Technologies Limited Announces Management ChangesCovidh Technologies Limited announced that the present management of the company has resigned from office in compliance with NCLT Order bearing number 393/2021 which was pronounced on 10th of January, 2022. As per the said Order, the new management of the company has been taken over by Mr. Ganapa Narsi Reddy. The new management namely Mr. Ganapa Narsi Reddy is having about 13 years of experience in the field of education, technical and consultancy services. The said change in the management has been discussed in the Board and taken note of it.株主還元534920IN SoftwareIN 市場7D0%4.4%2.1%1Yn/a-14.2%0.8%株主還元を見る業界別リターン: 534920がIndian Software業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: 534920 Indian市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is 534920's price volatile compared to industry and market?534920 volatility534920 Average Weekly Movement1.9%Software Industry Average Movement7.8%Market Average Movement7.2%10% most volatile stocks in IN Market10.3%10% least volatile stocks in IN Market4.8%安定した株価: 534920 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 534920の 週次ボラティリティ ( 2% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1993n/aJayshree Suresh Jainwww.covidhtechnologies.comCovidh Technologies LimitedはインドでIT/ITES事業を展開。様々な業界向けにデジタルトランスフォーメーション、ビジネスプロセスアウトソーシング、データ処理サービスを提供している。同社のサービスには、財務データ処理、文書管理、スキャン、デジタル変換、バックオフィス・オフサイト・サポート・サービス、ITインフラ管理などがある。さらに、ウェブ、モバイル、デスクトップ向けのソフトウェア開発サービス、Windows/Linux/Android/Macオペレーティングシステム向けのクロスプラットフォーム開発サービスも提供している。同社は以前はアプタス・インダストリーズ・リミテッドとして知られていたが、2014年4月にコヴィド・テクノロジーズ・リミテッドに社名を変更した。同社は1993年に法人化され、インドのハイデラバードに本社を置いている。もっと見るiSERA Lifesciences Limited 基礎のまとめiSERA Lifesciences の収益と売上を時価総額と比較するとどうか。534920 基礎統計学時価総額₹651.61m収益（TTM）₹2.59m売上高(TTM)₹14.25m251.2xPER（株価収益率45.7xP/Sレシオ534920 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計534920 損益計算書（TTM）収益₹14.25m売上原価₹4.50m売上総利益₹9.75mその他の費用₹7.16m収益₹2.59m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.31グロス・マージン68.43%純利益率18.20%有利子負債／自己資本比率20.2%534920 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 07:11終値2026/05/27 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋iSERA Lifesciences Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 15iSERA Lifesciences Limited to Report Q4, 2026 Results on May 21, 2026iSERA Lifesciences Limited announced that they will report Q4, 2026 results on May 21, 2026
Board Change • May 01High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. MD & Director Jayshree Suresh Jain is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Apr 02Covidh Technologies Limited Approves Directorate AppointmentsCovidh Technologies Limited at its EGM held on April 2, 2026 approved the appointment of Mr. Dhairyasheel Vasantrao Yadav as an Executive Director of the Company; approved the appointment of Mr. Nandkumar Subhash Kadam as an Executive Director of the Company; approved the appointment of Mr. Pratap Dadasaheb Deshmuk as a Non-Executive, Non-Independent Director of the Company and approved the appointment of Ms Ritu Dhanraj Garad as a Non-Executive, Non-Independent Director of the Company.
お知らせ • Feb 24Covidh Technologies Limited (BSE:534920) entered into a non-binding letter of intent to acquire Isera Biological Private Limited.Covidh Technologies Limited (BSE:534920) entered into a non-binding letter of intent to acquire Isera Biological Private Limited on February 23, 2026. The proposed acquisition is subject to execution of definitive agreements, completion of satisfactory due diligence, receipt of necessary regulatory, statutory and shareholders' approvals, and fulfilment of agreed conditions precedent. Upon completion of the proposed transaction. iSERA shall become a wholly owned subsidiary of Covidh Technologies Limited.
お知らせ • Feb 05Covidh Technologies Limited to Report Q3, 2026 Results on Feb 10, 2026Covidh Technologies Limited announced that they will report Q3, 2026 results on Feb 10, 2026
New Risk • Nov 13New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 25x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-₹980k). Shareholders have been substantially diluted in the past year (over 25x increase in shares outstanding). Revenue is less than US$1m (₹2.7m revenue, or US$30k). Market cap is less than US$10m (₹75.3m market cap, or US$849.4k).
お知らせ • May 15iSERA Lifesciences Limited to Report Q4, 2026 Results on May 21, 2026iSERA Lifesciences Limited announced that they will report Q4, 2026 results on May 21, 2026
Board Change • May 01High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. MD & Director Jayshree Suresh Jain is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Apr 02Covidh Technologies Limited Approves Directorate AppointmentsCovidh Technologies Limited at its EGM held on April 2, 2026 approved the appointment of Mr. Dhairyasheel Vasantrao Yadav as an Executive Director of the Company; approved the appointment of Mr. Nandkumar Subhash Kadam as an Executive Director of the Company; approved the appointment of Mr. Pratap Dadasaheb Deshmuk as a Non-Executive, Non-Independent Director of the Company and approved the appointment of Ms Ritu Dhanraj Garad as a Non-Executive, Non-Independent Director of the Company.
お知らせ • Feb 24Covidh Technologies Limited (BSE:534920) entered into a non-binding letter of intent to acquire Isera Biological Private Limited.Covidh Technologies Limited (BSE:534920) entered into a non-binding letter of intent to acquire Isera Biological Private Limited on February 23, 2026. The proposed acquisition is subject to execution of definitive agreements, completion of satisfactory due diligence, receipt of necessary regulatory, statutory and shareholders' approvals, and fulfilment of agreed conditions precedent. Upon completion of the proposed transaction. iSERA shall become a wholly owned subsidiary of Covidh Technologies Limited.
お知らせ • Feb 05Covidh Technologies Limited to Report Q3, 2026 Results on Feb 10, 2026Covidh Technologies Limited announced that they will report Q3, 2026 results on Feb 10, 2026
New Risk • Nov 13New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 25x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-₹980k). Shareholders have been substantially diluted in the past year (over 25x increase in shares outstanding). Revenue is less than US$1m (₹2.7m revenue, or US$30k). Market cap is less than US$10m (₹75.3m market cap, or US$849.4k).
お知らせ • Nov 11Covidh Technologies Limited to Report Q2, 2026 Results on Nov 13, 2025Covidh Technologies Limited announced that they will report Q2, 2026 results on Nov 13, 2025
Board Change • Sep 01High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. MD & Director Jayshree Jain is the most experienced director on the board, commencing their role in 2024. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 04Covidh Technologies Limited, Annual General Meeting, Aug 26, 2025Covidh Technologies Limited, Annual General Meeting, Aug 26, 2025, at 12:00 Indian Standard Time.
お知らせ • Aug 01Covidh Technologies Limited Announces Reconstitution of Committees of the BoardThe reconstitution of various Committees of the Board of Covidh Technologies Limited is as follows: For the Audit Committee, the members are as follows: S. No. 1, Apurva Pradeep Joshi, who serves as the Chairperson and is a Non-Executive Independent Director; S. No. 2, Rinku Saini, who is a Member and also a Non-Executive Independent Director; and S. No. 3, Mangina Srinivas Rao, who is a Member and a Non-Executive Independent Director. Moving on to the Nomination and Remuneration Committee (NRC), the members are: S. No. 1, Apurva Pradeep Joshi, serving as the Chairperson and a Non-Executive Independent Director; S. No. 2, Rinku Saini, who is a Member and a Non-Executive Independent Director; and S. No. 3, Mangina Srinivas Rao, who is a Member and a Non-Executive Independent Director. For the Stakeholders Relationship Committee (SRC), the members are: S. No. 1, Apurva Pradeep Joshi, who is the Chairperson and a Non-Executive Independent Director; S. No. 2, Rinku Saini, who is a Member and a Non-Executive Independent Director; and S. No. 3, Mangina Srinivas Rao, who is a Member and a Non-Executive Independent Director. Lastly, for the Risk Management Committee, the members are: S. No. 1, Apurva Pradeep Joshi, who serves as the Chairperson and is a Non-Executive Independent Director; S. No. 2, Rinku Saini, who is a Member and a Non-Executive Independent Director; and S. No. 3, Mangina Srinivas Rao, who is a Member and a Non-Executive Independent Director.
お知らせ • Jul 29Covidh Technologies Limited to Report Q1, 2026 Results on Aug 01, 2025Covidh Technologies Limited announced that they will report Q1, 2026 results on Aug 01, 2025
お知らせ • May 27Covidh Technologies Limited to Report Q4, 2025 Results on May 30, 2025Covidh Technologies Limited announced that they will report Q4, 2025 results at 12:15 PM, Indian Standard Time on May 30, 2025
お知らせ • Mar 25Covidh Technologies Limited Announces Resignation of Ms. Vinita Dilip Modak as Independent DirectorCovidh Technologies Limited announced that Ms. Vinita Dilip Modak has resigned from the post of Independent Director from the Board of the Company with effect from the closure of business hour from March 24, 2025 due to other professional commitments. She has confirmed that there are no material reasons for her resignation other than those mentioned in her resignation letter. Name of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of Board Committees: Directorship of Davangere Sugar Company. Committees: Stakeholders Relationship Committee; Member of Committee in Davangere Sugar Company Limited, Corporate Social Responsibility Committee; Member of Committee in Davangere Sugar Company Limited.
お知らせ • Feb 03Covidh Technologies Limited to Report Q3, 2025 Results on Feb 10, 2025Covidh Technologies Limited announced that they will report Q3, 2025 results on Feb 10, 2025
お知らせ • Nov 09Covidh Technologies Limited to Report Q2, 2025 Results on Nov 13, 2024Covidh Technologies Limited announced that they will report Q2, 2025 results on Nov 13, 2024
お知らせ • Oct 24Covidh Technologies Limited Announces Resignation of Suresh Fatehlalji Jain as Executive DirectorCovidh Technologies Limited announced that at the board meeting held on 24 October, 2024 approved the resignation of Mr. Suresh Fatehlalji Jain from the post of Executive Director of the Company with effect from 24 October, 2024 due to personal and unavoidable circumstances.
お知らせ • Aug 30Covidh Technologies Limited Announces Board AppointmentsThe board of directors of Covidh Technologies Limited meeting held on August 28, 2024, considered and approved the appointment of Mr. Suresh Fatehlalji Jain as an Additional Executive Director of the company with effect from August 28, 2024 and Mrs. Jayshree Babulal Jain as an Additional Non-Executive Director of the company with effect from August 28, 2024. Mr. Suresh Fatehlalji Jain brings over seven years of rich experience in Marketing and Sales. Throughout his career, he has developed a strong acumen for market analysis, strategic planning, and driving sales growth. His expertise in these areas has enabled him to consistently deliver impressive results, positioning him as a key contributor to the success of the organizations he has served. Mr. Kumar's deep understanding of market dynamics and customer behavior makes him a highly effective leader in the marketing and sales domain. Mrs. Jayshree Babulal Jain has accumulated over four years of extensive experience in the fields of Administration and Operations. Her expertise lies in streamlining administrative processes and optimizing operational efficiency, contributing to the effective management and growth of the organizations She has been a part of. Her hands-on approach and in-depth knowledge make her a valuable asset in driving organizational success.
お知らせ • Aug 12Covidh Technologies Limited, Annual General Meeting, Sep 30, 2024Covidh Technologies Limited, Annual General Meeting, Sep 30, 2024.
お知らせ • Aug 07Covidh Technologies Limited to Report Q1, 2025 Results on Aug 12, 2024Covidh Technologies Limited announced that they will report Q1, 2025 results on Aug 12, 2024
お知らせ • May 22Covidh Technologies Limited to Report Q4, 2024 Results on May 29, 2024Covidh Technologies Limited announced that they will report Q4, 2024 results on May 29, 2024
New Risk • Jan 30New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 34x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹1.5m free cash flow). Shares are highly illiquid. Negative equity (-₹1.4m). Shareholders have been substantially diluted in the past year (over 34x increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (₹19.7m market cap, or US$237.2k).
お知らせ • Jan 26Covidh Technologies Limited to Report Q3, 2024 Results on Feb 08, 2024Covidh Technologies Limited announced that they will report Q3, 2024 results on Feb 08, 2024
お知らせ • Nov 04Covidh Technologies Limited to Report Q2, 2024 Results on Nov 10, 2023Covidh Technologies Limited announced that they will report Q2, 2024 results on Nov 10, 2023
Board Change • Sep 18High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 08Covidh Technologies Limited, Annual General Meeting, Sep 30, 2023Covidh Technologies Limited, Annual General Meeting, Sep 30, 2023, at 10:00 Indian Standard Time. Location: Flat No 302, Plot No 159, Ayyappa Society, Madhapur, Hyderabad 500081 Hyderabad Andhra Pradesh India Agenda: To receive, consider and adopt the Audited Balance Sheet as at 31st March 2023, the Profit and Loss Account for the year ended on that date, Cash flow for the year ended on that date and the Reports of the Directors and Auditors thereon.
Board Change • Sep 04High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 05Covidh Technologies Limited to Report Q1, 2024 Results on Aug 11, 2023Covidh Technologies Limited announced that they will report Q1, 2024 results on Aug 11, 2023
お知らせ • May 23Covidh Technologies Limited to Report Fiscal Year 2023 Results on May 29, 2023Covidh Technologies Limited announced that they will report fiscal year 2023 results on May 29, 2023
Board Change • May 02High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 20High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 06High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Feb 04Covidh Technologies Limited to Report Q3, 2023 Results on Feb 13, 2023Covidh Technologies Limited announced that they will report Q3, 2023 results on Feb 13, 2023
Board Change • Nov 21High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 06Covidh Technologies Limited to Report Q2, 2023 Results on Nov 14, 2022Covidh Technologies Limited announced that they will report Q2, 2023 results on Nov 14, 2022
Board Change • Oct 11High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Non-Executive & Independent Director Ganesh Amirineni is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 07Covidh Technologies Limited, Annual General Meeting, Sep 29, 2022Covidh Technologies Limited, Annual General Meeting, Sep 29, 2022, at 10:00 Indian Standard Time. Location: House No.1-10-27/34/15A, Prakash Nagar, Begumpet, Secunderabad Hyderabad India
お知らせ • Aug 30Covidh Technologies Limited to Report Fiscal Year 2022 Final Results on Sep 05, 2022Covidh Technologies Limited announced that they will report fiscal year 2022 final results at 3:30 PM, Indian Standard Time on Sep 05, 2022
お知らせ • Aug 08Covidh Technologies Limited to Report Q1, 2023 Results on Aug 13, 2022Covidh Technologies Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 13, 2022
お知らせ • Jun 12Covidh Technologies Limited Appoints Hema Gupta as Whole-Time Company Secretary and Compliance OfficerThe board of directors of Covidh Technologies Limited at its meeting held on June 11, 2022, appointed, Mrs. Hema Kumari, an Associate member of Institute of Company Secretaries of India (Membership No: A48642) as whole-time company secretary and compliance officer, with the effect from June 11, 2022.
お知らせ • May 31Covidh Technologies Limited Approves Resignation of Mr. Phani Kumar.B as CFO, Effective on May 31, 2022Covidh Technologies Limited announced that at its board meeting held on May 30, 2022, the board approved the resignation of Mr. Phani Kumar.B as CFO of the company with effect from closing of the business hours of the 31st May, 2022.
お知らせ • May 20Covidh Technologies Limited to Report Q4, 2022 Results on May 30, 2022Covidh Technologies Limited announced that they will report Q4, 2022 results on May 30, 2022
お知らせ • Feb 16Covidh Technologies Limited Announces Management ChangesCovidh Technologies Limited announced that the present management of the company has resigned from office in compliance with NCLT Order bearing number 393/2021 which was pronounced on 10th of January, 2022. As per the said Order, the new management of the company has been taken over by Mr. Ganapa Narsi Reddy. The new management namely Mr. Ganapa Narsi Reddy is having about 13 years of experience in the field of education, technical and consultancy services. The said change in the management has been discussed in the Board and taken note of it.
